Your browser doesn't support javascript.
loading
A multi-center phase II study of BMS-247550 (Ixabepilone) by two schedules in patients with metastatic gastric adenocarcinoma previously treated with a taxane.
Ajani, J A; Safran, H; Bokemeyer, C; Shah, M A; Lenz, H-J; Van Cutsem, E; Burris, H A; Lebwohl, D; Mullaney, B.
Affiliation
  • Ajani JA; The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Mail Stop 426, Houston, Texas, 77030, USA. jajani@mdanderson.org
Invest New Drugs ; 24(5): 441-6, 2006 Sep.
Article in En | MEDLINE | ID: mdl-16586011
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Adenocarcinoma / Epothilones / Antineoplastic Agents Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Invest New Drugs Year: 2006 Document type: Article Affiliation country: Estados Unidos
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Adenocarcinoma / Epothilones / Antineoplastic Agents Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Invest New Drugs Year: 2006 Document type: Article Affiliation country: Estados Unidos